Asthma/COPD Combination Medication Market, Global Outlook and Forecast 2022-2028

March 2022 | 63 pages | ID: A3D3DFBB3CE3EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Asthma/COPD Combination Medication in Global, including the following market information:

Global Asthma/COPD Combination Medication Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Asthma/COPD Combination Medication market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Budesonide Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Asthma/COPD Combination Medication include AstraZeneca, GSK, Boehringer Ingelheim Pharmaceuticals, Sunovion Pharmaceuticals Inc, Novartis and Circassia Pharmaceuticals Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Asthma/COPD Combination Medication companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Asthma/COPD Combination Medication Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Asthma/COPD Combination Medication Market Segment Percentages, by Type, 2021 (%)

• Budesonide
• LAMA/LABA Combo
• Fluticasone/Salmeterol

Global Asthma/COPD Combination Medication Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Asthma/COPD Combination Medication Market Segment Percentages, by Application, 2021 (%)

• Moderate COPD
• Severe COPD
• Asthma

Global Asthma/COPD Combination Medication Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Asthma/COPD Combination Medication Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Asthma/COPD Combination Medication revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Asthma/COPD Combination Medication revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AstraZeneca
• GSK
• Boehringer Ingelheim Pharmaceuticals
• Sunovion Pharmaceuticals Inc
• Novartis
• Circassia Pharmaceuticals Inc

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Asthma/COPD Combination Medication Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Asthma/COPD Combination Medication Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ASTHMA/COPD COMBINATION MEDICATION OVERALL MARKET SIZE

2.1 Global Asthma/COPD Combination Medication Market Size: 2021 VS 2028
2.2 Global Asthma/COPD Combination Medication Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Asthma/COPD Combination Medication Players in Global Market
3.2 Top Global Asthma/COPD Combination Medication Companies Ranked by Revenue
3.3 Global Asthma/COPD Combination Medication Revenue by Companies
3.4 Top 3 and Top 5 Asthma/COPD Combination Medication Companies in Global Market, by Revenue in 2021
3.5 Global Companies Asthma/COPD Combination Medication Product Type
3.6 Tier 1, Tier 2 and Tier 3 Asthma/COPD Combination Medication Players in Global Market
  3.6.1 List of Global Tier 1 Asthma/COPD Combination Medication Companies
  3.6.2 List of Global Tier 2 and Tier 3 Asthma/COPD Combination Medication Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Asthma/COPD Combination Medication Market Size Markets, 2021 & 2028
  4.1.2 Budesonide
  4.1.3 LAMA/LABA Combo
  4.1.4 Fluticasone/Salmeterol
4.2 By Type - Global Asthma/COPD Combination Medication Revenue & Forecasts
  4.2.1 By Type - Global Asthma/COPD Combination Medication Revenue, 2017-2022
  4.2.2 By Type - Global Asthma/COPD Combination Medication Revenue, 2023-2028
  4.2.3 By Type - Global Asthma/COPD Combination Medication Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Asthma/COPD Combination Medication Market Size, 2021 & 2028
  5.1.2 Moderate COPD
  5.1.3 Severe COPD
  5.1.4 Asthma
5.2 By Application - Global Asthma/COPD Combination Medication Revenue & Forecasts
  5.2.1 By Application - Global Asthma/COPD Combination Medication Revenue, 2017-2022
  5.2.2 By Application - Global Asthma/COPD Combination Medication Revenue, 2023-2028
  5.2.3 By Application - Global Asthma/COPD Combination Medication Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Asthma/COPD Combination Medication Market Size, 2021 & 2028
6.2 By Region - Global Asthma/COPD Combination Medication Revenue & Forecasts
  6.2.1 By Region - Global Asthma/COPD Combination Medication Revenue, 2017-2022
  6.2.2 By Region - Global Asthma/COPD Combination Medication Revenue, 2023-2028
  6.2.3 By Region - Global Asthma/COPD Combination Medication Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Asthma/COPD Combination Medication Revenue, 2017-2028
  6.3.2 US Asthma/COPD Combination Medication Market Size, 2017-2028
  6.3.3 Canada Asthma/COPD Combination Medication Market Size, 2017-2028
  6.3.4 Mexico Asthma/COPD Combination Medication Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Asthma/COPD Combination Medication Revenue, 2017-2028
  6.4.2 Germany Asthma/COPD Combination Medication Market Size, 2017-2028
  6.4.3 France Asthma/COPD Combination Medication Market Size, 2017-2028
  6.4.4 U.K. Asthma/COPD Combination Medication Market Size, 2017-2028
  6.4.5 Italy Asthma/COPD Combination Medication Market Size, 2017-2028
  6.4.6 Russia Asthma/COPD Combination Medication Market Size, 2017-2028
  6.4.7 Nordic Countries Asthma/COPD Combination Medication Market Size, 2017-2028
  6.4.8 Benelux Asthma/COPD Combination Medication Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Asthma/COPD Combination Medication Revenue, 2017-2028
  6.5.2 China Asthma/COPD Combination Medication Market Size, 2017-2028
  6.5.3 Japan Asthma/COPD Combination Medication Market Size, 2017-2028
  6.5.4 South Korea Asthma/COPD Combination Medication Market Size, 2017-2028
  6.5.5 Southeast Asia Asthma/COPD Combination Medication Market Size, 2017-2028
  6.5.6 India Asthma/COPD Combination Medication Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Asthma/COPD Combination Medication Revenue, 2017-2028
  6.6.2 Brazil Asthma/COPD Combination Medication Market Size, 2017-2028
  6.6.3 Argentina Asthma/COPD Combination Medication Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Asthma/COPD Combination Medication Revenue, 2017-2028
  6.7.2 Turkey Asthma/COPD Combination Medication Market Size, 2017-2028
  6.7.3 Israel Asthma/COPD Combination Medication Market Size, 2017-2028
  6.7.4 Saudi Arabia Asthma/COPD Combination Medication Market Size, 2017-2028
  6.7.5 UAE Asthma/COPD Combination Medication Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AstraZeneca
  7.1.1 AstraZeneca Corporate Summary
  7.1.2 AstraZeneca Business Overview
  7.1.3 AstraZeneca Asthma/COPD Combination Medication Major Product Offerings
  7.1.4 AstraZeneca Asthma/COPD Combination Medication Revenue in Global Market (2017-2022)
  7.1.5 AstraZeneca Key News
7.2 GSK
  7.2.1 GSK Corporate Summary
  7.2.2 GSK Business Overview
  7.2.3 GSK Asthma/COPD Combination Medication Major Product Offerings
  7.2.4 GSK Asthma/COPD Combination Medication Revenue in Global Market (2017-2022)
  7.2.5 GSK Key News
7.3 Boehringer Ingelheim Pharmaceuticals
  7.3.1 Boehringer Ingelheim Pharmaceuticals Corporate Summary
  7.3.2 Boehringer Ingelheim Pharmaceuticals Business Overview
  7.3.3 Boehringer Ingelheim Pharmaceuticals Asthma/COPD Combination Medication Major Product Offerings
  7.3.4 Boehringer Ingelheim Pharmaceuticals Asthma/COPD Combination Medication Revenue in Global Market (2017-2022)
  7.3.5 Boehringer Ingelheim Pharmaceuticals Key News
7.4 Sunovion Pharmaceuticals Inc
  7.4.1 Sunovion Pharmaceuticals Inc Corporate Summary
  7.4.2 Sunovion Pharmaceuticals Inc Business Overview
  7.4.3 Sunovion Pharmaceuticals Inc Asthma/COPD Combination Medication Major Product Offerings
  7.4.4 Sunovion Pharmaceuticals Inc Asthma/COPD Combination Medication Revenue in Global Market (2017-2022)
  7.4.5 Sunovion Pharmaceuticals Inc Key News
7.5 Novartis
  7.5.1 Novartis Corporate Summary
  7.5.2 Novartis Business Overview
  7.5.3 Novartis Asthma/COPD Combination Medication Major Product Offerings
  7.5.4 Novartis Asthma/COPD Combination Medication Revenue in Global Market (2017-2022)
  7.5.5 Novartis Key News
7.6 Circassia Pharmaceuticals Inc
  7.6.1 Circassia Pharmaceuticals Inc Corporate Summary
  7.6.2 Circassia Pharmaceuticals Inc Business Overview
  7.6.3 Circassia Pharmaceuticals Inc Asthma/COPD Combination Medication Major Product Offerings
  7.6.4 Circassia Pharmaceuticals Inc Asthma/COPD Combination Medication Revenue in Global Market (2017-2022)
  7.6.5 Circassia Pharmaceuticals Inc Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Asthma/COPD Combination Medication Market Opportunities & Trends in Global Market
Table 2. Asthma/COPD Combination Medication Market Drivers in Global Market
Table 3. Asthma/COPD Combination Medication Market Restraints in Global Market
Table 4. Key Players of Asthma/COPD Combination Medication in Global Market
Table 5. Top Asthma/COPD Combination Medication Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Asthma/COPD Combination Medication Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Asthma/COPD Combination Medication Revenue Share by Companies, 2017-2022
Table 8. Global Companies Asthma/COPD Combination Medication Product Type
Table 9. List of Global Tier 1 Asthma/COPD Combination Medication Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Asthma/COPD Combination Medication Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Asthma/COPD Combination Medication Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Asthma/COPD Combination Medication Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Asthma/COPD Combination Medication Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Asthma/COPD Combination Medication Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Asthma/COPD Combination Medication Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Asthma/COPD Combination Medication Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Asthma/COPD Combination Medication Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Asthma/COPD Combination Medication Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Asthma/COPD Combination Medication Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Asthma/COPD Combination Medication Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Asthma/COPD Combination Medication Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Asthma/COPD Combination Medication Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Asthma/COPD Combination Medication Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Asthma/COPD Combination Medication Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Asthma/COPD Combination Medication Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Asthma/COPD Combination Medication Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Asthma/COPD Combination Medication Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Asthma/COPD Combination Medication Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Asthma/COPD Combination Medication Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca Asthma/COPD Combination Medication Product Offerings
Table 32. AstraZeneca Asthma/COPD Combination Medication Revenue (US$, Mn), (2017-2022)
Table 33. GSK Corporate Summary
Table 34. GSK Asthma/COPD Combination Medication Product Offerings
Table 35. GSK Asthma/COPD Combination Medication Revenue (US$, Mn), (2017-2022)
Table 36. Boehringer Ingelheim Pharmaceuticals Corporate Summary
Table 37. Boehringer Ingelheim Pharmaceuticals Asthma/COPD Combination Medication Product Offerings
Table 38. Boehringer Ingelheim Pharmaceuticals Asthma/COPD Combination Medication Revenue (US$, Mn), (2017-2022)
Table 39. Sunovion Pharmaceuticals Inc Corporate Summary
Table 40. Sunovion Pharmaceuticals Inc Asthma/COPD Combination Medication Product Offerings
Table 41. Sunovion Pharmaceuticals Inc Asthma/COPD Combination Medication Revenue (US$, Mn), (2017-2022)
Table 42. Novartis Corporate Summary
Table 43. Novartis Asthma/COPD Combination Medication Product Offerings
Table 44. Novartis Asthma/COPD Combination Medication Revenue (US$, Mn), (2017-2022)
Table 45. Circassia Pharmaceuticals Inc Corporate Summary
Table 46. Circassia Pharmaceuticals Inc Asthma/COPD Combination Medication Product Offerings
Table 47. Circassia Pharmaceuticals Inc Asthma/COPD Combination Medication Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Asthma/COPD Combination Medication Segment by Type in 2021
Figure 2. Asthma/COPD Combination Medication Segment by Application in 2021
Figure 3. Global Asthma/COPD Combination Medication Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Asthma/COPD Combination Medication Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Asthma/COPD Combination Medication Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Asthma/COPD Combination Medication Revenue in 2021
Figure 8. By Type - Global Asthma/COPD Combination Medication Revenue Market Share, 2017-2028
Figure 9. By Application - Global Asthma/COPD Combination Medication Revenue Market Share, 2017-2028
Figure 10. By Region - Global Asthma/COPD Combination Medication Revenue Market Share, 2017-2028
Figure 11. By Country - North America Asthma/COPD Combination Medication Revenue Market Share, 2017-2028
Figure 12. US Asthma/COPD Combination Medication Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Asthma/COPD Combination Medication Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Asthma/COPD Combination Medication Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Asthma/COPD Combination Medication Revenue Market Share, 2017-2028
Figure 16. Germany Asthma/COPD Combination Medication Revenue, (US$, Mn), 2017-2028
Figure 17. France Asthma/COPD Combination Medication Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Asthma/COPD Combination Medication Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Asthma/COPD Combination Medication Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Asthma/COPD Combination Medication Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Asthma/COPD Combination Medication Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Asthma/COPD Combination Medication Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Asthma/COPD Combination Medication Revenue Market Share, 2017-2028
Figure 24. China Asthma/COPD Combination Medication Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Asthma/COPD Combination Medication Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Asthma/COPD Combination Medication Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Asthma/COPD Combination Medication Revenue, (US$, Mn), 2017-2028
Figure 28. India Asthma/COPD Combination Medication Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Asthma/COPD Combination Medication Revenue Market Share, 2017-2028
Figure 30. Brazil Asthma/COPD Combination Medication Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Asthma/COPD Combination Medication Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Asthma/COPD Combination Medication Revenue Market Share, 2017-2028
Figure 33. Turkey Asthma/COPD Combination Medication Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Asthma/COPD Combination Medication Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Asthma/COPD Combination Medication Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Asthma/COPD Combination Medication Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca Asthma/COPD Combination Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GSK Asthma/COPD Combination Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Boehringer Ingelheim Pharmaceuticals Asthma/COPD Combination Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sunovion Pharmaceuticals Inc Asthma/COPD Combination Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis Asthma/COPD Combination Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Circassia Pharmaceuticals Inc Asthma/COPD Combination Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)